Acorn Bioventures, L.P.

Insider Reports History

Location: 295 Madison Avenue, 32 Nd Fl, New York, NY
Signature: ACORN BIOVENTURES, L.P., By: Acorn Capital Advisors GP, LLC, its general partner, By: /s/ Anders Hove, Manager
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Acorn Bioventures, L.P.:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Reneo Pharmaceuticals, Inc.	10%+ Owner	Class A Common Stock	1.44M	$3.85M	$2.67	Oct 4, 2024	Direct
OnKure Therapeutics, Inc.	10%+ Owner	Common Stock	1.71M	$3.16M	$1.85	May 15, 2025	Direct
OnKure Therapeutics, Inc.	10%+ Owner	Common Stock	1.13M	$2.09M	$1.85	May 15, 2025	By Acorn Bioventures 2, L.P.

Showing 1 to 3 of 3 entries

Insider Reports Filed by Acorn Bioventures, L.P.

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
OKUR	OnKure Therapeutics, Inc.	May 15, 2025	2	$2.59M	4	May 19, 2025	10%+ Owner
OKUR	OnKure Therapeutics, Inc.	Oct 4, 2024	0	$0	3	Oct 9, 2024	10%+ Owner